Aprecia, The 3DP Pharmaceutical Company, expects to use its ZipDose® Technology to transform the way people take medicine. Its first innovation, ZipDose Technology can be combined with a wide variety of active pharmaceutical ingredients to create rapidly disintegrating oral dosage forms that are easy to take and easy to administer. Aprecia is committed to enhancing the patient experience through novel approaches to drug delivery that address unmet treatment needs to eliminate patient suffering and caregiver burden.
External link for Aprecia Pharmaceuticals
10901 Kenwood Road
Blue Ash, Ohio 45242, US
Aprecia Pharmaceuticals reposted this
Come join my team! Looking to add a few key skill sets. Ping me if you're interested or know someone who is!
At Aprecia, we strive every day to imagine, inspire, and transform the new age of digital medicine. We are hiring at Aprecia! Apply today at https://lnkd.in/exMy5ch6
Proper tablet dispensing practices were evident and followed even in the 1800’s. Technology has evolved since then by using automation to dispense and computers to control the process. #nationalinventorsday2024 #pharmaindustry #innovation #techcompany
Aprecia Pharmaceuticals is excited to announce our new Chief Commercial Officer Andrew Karazim. Andrew brings more than 25 years of pharmaceutical and biotechnology experience with expertise across sales, marketing and market access. “Aprecia has a legacy of innovation in pharmaceutical product development and manufacturing. Its 3DP technology and expertise creates a variety of functionally differentiated drug products previously unachievable with traditional manufacturing,” Karazim said. “I am excited to join this passionate team of experts focused on transforming medication aimed at improving patients’ lives.” Welcome to the team Andrew! #pharmaindustry #innovation #manufacturing
In recognition of #nationalinventorsday2024 this Sunday, we would like to thank those inventors who are responsible for improving the lives of people everywhere, including our formulation scientists at Aprecia. Our own Gary Street shared his personal collection of active pharmaceutical ingredients from the 1860. #pharmaindustry #innovation #techcompany
Aprecia's Siddhant Palekar's latest review article 'Formulation strategies for the development of high drug-loaded amorphous solid dispersions' was recently published in Drug Discovery Today by Elsevier. The article highlights the benefits of Amorphous solid dispersions (ASDs) and how the technology enhances the solubility and bioavailability of poorly water-soluble drugs. Siddhant Palekar also shares numerous formulation strategies for developing amorphous solid dispersions. #AmorphousSolidDispersions #HighDrugLoading #PatelResearchLab #biopharmaceutical #innovation
Thank you Michael Pistone for your work at #bioeurope2023 and for driving #3dprintingtechnology in biopharma forward. #pharmtech
Coming off a great week in Munich at #bioeurope2023. Great event as always from EBD Group and Michelle Cheesbrough! Aprecia Pharmaceuticals was pleased to meet with many current and potential partners from across the globe. …and 🥨 for breakfast, lunch, and dinner!
Thank you to the presenter, attendees, and staff of American Association of Pharmaceutical Scientists (AAPS) | @aapscomms #pharmsci360. This year's conference was informative and energizing. Looking forward to next year. #pharmaindustry #pharmtech #medicinereimagined
Aprecia Pharmaceuticals reposted this
One of many wow moments for those who tried our demonstrators. #pharmtech #medicinereimagined #aaps
One of many wow moments for those who tried our demonstrators. #pharmtech #medicinereimagined #aaps
Michelle Schilling, PhD is about to share her poster on manufacturing low-dose rapidily disintergrating dosages using 3DP binder jetting. If you missed her session, visit her at booth #2335 to learn more. #pharmtech #3DP #medicinereimagined